Driving RetirementChallenging Conversations in Community Mobility

Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and The Alzheimer's Association. ACHL is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement: The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

(NOTE: Nurse practitioners may participate in this educational activity and earn a certificate of completing as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.)

Content Contributors

Faculty

David B. Carr, MD

Washington University School of Medicine

Alan A. and Edith L. Wolff Professor of Geriatric Medicine

Professor of Medicine and Neurology

Clinical Director

Division of Geriatrics and Nutritional Science

Division of Neurorehabilitation

Medical Director

The Rehabilitation Institute of St. Louis (TRISL)

Parc Provence

St. Louis, MO

Release date: 02/15/2022

Expiration date: 02/15/2023

Disclosure Statements

Faculty Disclosures

The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been mitigated prior to this activity.

The following financial relationships have been provided:

David B. Carr, MD

Clinical Investigator: IQVIA (Green Memory Trial) and Roche

Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None.

Staff and Reviewer Disclosures

ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Disclaimer

The content for this activity was developed independently. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher.

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers' prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

Sponsorship

Sponsored by the Academy for Continued Healthcare Learning (ACHL).

Target Audience

This activity is intended for primary care clinicians including internists, family physicians, nurse practitioners, and physician assistants who work with patients with cognitive impairment or dementia.